SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-23-031954
Filing Date
2023-06-28
Accepted
2023-06-28 16:58:32
Documents
2
Period of Report
2023-06-22

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 1423
2 EXHIBIT 24 brhc20055145_ex24.htm EX-24 12684
  Complete submission text file 0001140361-23-031954.txt   15421
Mailing Address C/O MIRATI THERAPEUTICS INC. 9393 TOWNE CENTRE DRIVE, STE 200 SAN DIEGO CA 92121
Business Address
BAUM CHARLES M (Reporting) CIK: 0001579824 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41551 | Film No.: 231052969

Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Issuer) CIK: 0001781174 (see all company filings)

IRS No.: 825125532 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations